Form 4: Eli Lilly Executive Ilya Yuffa Reports Stock Transactions
SEC Form 4 Filing
EVP & President of Eli Lilly International, Ilya Yuffa, reports the acquisition and disposal of company stock on February 1, 2025.
Summary
- On February 1, 2025, Ilya Yuffa, EVP & President of Eli Lilly International, reported transactions involving Eli Lilly & Co. common stock.
- Yuffa acquired 3,269 shares of common stock through the exercise of restricted stock units.
- Simultaneously, Yuffa disposed of 1,434.377 shares to cover tax obligations at a price of $811.08.
- Following these transactions, Yuffa directly owns 21,636.623 shares of Eli Lilly & Co. common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports stock transactions by an executive, which is a routine occurrence.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the trading activities of key personnel within Eli Lilly.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders as they represent routine executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/01/2025 | Date of stock transactions (acquisition and disposal). |
| 02/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.